v3.25.2
Investment in Associates and Joint Ventures (Details) - USD ($)
$ in Thousands
12 Months Ended
Sep. 26, 2024
Mar. 11, 2024
Nov. 25, 2023
Feb. 17, 2023
Mar. 31, 2022
Mar. 10, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Investment in Associates [Line Items]                  
Initial investment amount           $ 700      
Cash consideration $ 700                
Purchaser remaining ownership 73.00%                
Purchaser equal valuation $ 8,000                
Equity losses from the investment             $ (429) $ (210) $ (109)
Minimum [Member]                  
Investment in Associates [Line Items]                  
Cash consideration 5,000                
Maximum [Member]                  
Investment in Associates [Line Items]                  
Cash consideration $ 7,000                
MitoCare X Bio Ltd [Member]                  
Investment in Associates [Line Items]                  
Additional investment           $ 1,000      
Ownership percentage           50.01%      
MitoCare X Bio Ltd [Member] | Bottom of range [Member]                  
Investment in Associates [Line Items]                  
Ownership percentage       31.48%          
MitoCare X Bio Ltd [Member] | Top of range [Member]                  
Investment in Associates [Line Items]                  
Ownership percentage       41.92%          
MitoCareX [Member]                  
Investment in Associates [Line Items]                  
Initial investment amount         $ 700        
Additional investment     $ 600 $ 400          
Ownership percentage 27.00%                
Outstanding shares                 31.48%
Additional installment     $ 600            
Installment paid   $ 600              
Cash consideration $ 700                
Purchaser equal valuation $ 5,000                
Issued and outstanding share 52.73%                
Equity losses from the investment               $ 210 $ 429
MitoCareX [Member] | Bottom of range [Member]                  
Investment in Associates [Line Items]                  
Ownership percentage     41.92%            
MitoCareX [Member] | Top of range [Member]                  
Investment in Associates [Line Items]                  
Ownership percentage     52.73%